LEXINGTON, Mass., June 4 /PRNewswire/ -- Indevus Pharmaceuticals, Inc. (Nasdaq: IDEV) today announced that based on a recent discussion with the U.S. Food and Drug Administration (FDA) regarding the ...
LEXINGTON, Mass., June 4 -- Indevus Pharmaceuticals, Inc. (Nasdaq: IDEV - News) today announced that based on a recent discussion with the U.S. Food and Drug Administration (FDA) regarding the NDA ...
LEXINGTON, Mass., Sept. 26 /PRNewswire-FirstCall/ -- Indevus Pharmaceuticals, Inc. (Nasdaq: IDEV) announced today that it has reached agreement with the U.S. Food and ...
BANGALORE, June 4 (Reuters) - Indevus Pharmaceuticals Inc's injectable testosterone drug's approval may be delayed by two years, as U.S. health regulators are expected to ask for more safety data, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results